NICE

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal

An Evidence Review Group Evaluation of the NICE Single Technology Appraisal for obinutuzumab in combination with chemotherapy for first-line treatment of advanced follicular lymphoma.